EFFETTO DELLA CDP-COLINA SUL DECADIMENTO MENTALE SENILE. ESPERIENZA POLICENTRICA SU 237 CASI

Translated title of the contribution: CDP-choline effect on brain aging. Multicenter experience on 237 patients

F. Serra, G. P. Diaspri, A. Gasbarrini, S. Giancane, A. Rimondi, M. R. Tame, E. Sakellaridis, M. Bernardi, G. Gasbarrini

Research output: Contribution to journalArticlepeer-review

Abstract

The efficacy of CDP-choline (1000 mg/die) administered for two-21 day treatment cycles, with a one-week wash-out period between them, was evaluated in out and in-patients suffering from mild to moderate brain aging. The study was performed on 237 fully evaluable patients with the use of the reduced geriatric scale of Plutchik and al., for clinical evaluation of the symptomatology. The clinical data obtained demonstrate that treatment with CDP-choline is able to determine an improvement of symptomatology since the 1st cycle of therapy (p

Translated title of the contributionCDP-choline effect on brain aging. Multicenter experience on 237 patients
Original languageItalian
Pages (from-to)465-470
Number of pages6
JournalMinerva Medica
Volume81
Issue number6
Publication statusPublished - 1990

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'CDP-choline effect on brain aging. Multicenter experience on 237 patients'. Together they form a unique fingerprint.

Cite this